Join the renaissance in psychedelic science

ICPR is returning: September 22nd to 24th, 2022

The 2020 conference has ended. Please click below to get access to early bird tickets for ICPR 2022!

All talks are recorded and made available to attendees.

Discounted tickets available for full access!

ICPR 2022 EARLY BIRD TICKETS

Leading experts in psychedelic research & therapy, psychiatry, neuroscience, psychology, and anthropology.

For academics, therapists, researchers, clinicians, and the general public in an interactive online environment.

Keynote lectures,

interactive panel discussions,

and practically

oriented workshops.

Accredited conference: CME credits through NVvP, FGzPT and VVGN for eligible attendees.

CONFIRMED SPEAKERS

Elizabeth nielson, phd

Psilocybin-Assisted Treatment for Alcohol Use Disorder

Leopardo yawa bane

The uses of Nixi pae in the Huni Kui tradition

MICHAEL MITHOEFER, phd

MDMA-assisted psychotherapy for PTSD:

updates & observations

JANIS PHELPS, phd

Training future psychedelic therapists

enzo tagliazucchi, phd

Neural and psychological correlates of inhaled DMT in naturalistic settings

RICK DOBLIN, phd

Development of MDMA-assisted psytherapy for PTSD

fernanda palhano-fontes, phd

New findings from a randomized placebo-controlled trial with ayahuasca for treatment-resistant depression

wade davis, phd

Lessons from a life-time of ethnobotanical research

MATTHEW JOHNSON, PhD

Psilocybin-occasioned mystical experiences

BEN SESSA, MD

MDMA-assisted psychotherapy for alcoholism

monnica williams, phd

Panel: Diversity, Equity and Access in Psychedelic Medicine

MORE SPEAKERS

PROGRAM OVERVIEW

THURSDAY

24 SEPTEMBER

DOORS OPEN

DAILY TIMES

16:00-22:00 Central European Time

10am-4pm Eastern Time

7am-1pm Pacific Time

FRIDAY

25 SEPTEMBER

SATURDAY

26 SEPTEMBER

THREE VIRTUAL STAGES

Hofmann Hall

Dobkin de Rios Room

Shulgin Stage

CONTENT AVAILABLE 24/7

Ticket holders can access the conference

until 6 months after the conference

SUNDAY

27 SEPTEMBER

THREE VIRTUAL STAGES

Hofmann Hall

Dobkin de Rios Room

Shulgin Stage

DAILY TIMES

16:00-22:00 Central European Time

10:00-16:00 Eastern Time

07:00-13:00 Pacific Time

CONTENT AVAILABLE 24/7

Ticket holders can access the conference

until 6 months after the conference

PROGRAM

TOPICS

DMT Research

Psilocybin Neuroscience

MDMA For PTSD

Microdosing – Pharmacology

Psilocybin For Depression: Inside Perspectives

Psychedelic Treatments For Alcoholism

Ayahuasca For Mental Health

Clinical Uses Of Ketamine

5-MeO-DMT Research

States Of Consciousness Research

Understanding Mechanisms Of Change

Psilocybin-assisted Psychotherapy

Beyond Symptom Reduction

Psychedelic & Psycholytic Therapy

Diversity, Equity And Access In Psychedelic Medicine

Medicalizing Psychedelics

Globalization Of Ayahuasca: Economy, Ethics, And Politics

And much more …!

NEWS

What is the future of legal MDMA?

MDMA is on the brink of becoming accepted as a legal medication in therapy. What will be its applications, its

Ayahuasca – Between Rainforest and the Laboratory

Anthropologists Jeremy Narby and David Dupuis discuss their experiences studying ayahuasca abroad and at home.

DMT and near-death experiences

Theories linking DMT to near-death-experiences have circulated persistently – yet the scientific evidence just doesn’t seem to be there.

Psychedelics: key to consciousness

By Alberto Cantizani Even if psychedelics have long been regarded as tools to explore or expand one’s consciousness, they have

The Science and Folklore of DMT

By Alberto Cantizani Being one of the most powerful psychedelics we know, it is not strange that DMT has become

ICPR 2020 Program now online

The ICPR 2020 Program is now online. Take a look at what the conference will look like.

How psychedelics can cause ‘the overview effect’

By Aleksi Hupli Neuroscientist Robin Carhart-Harris (PhD) studies the brain effects of LSD, psilocybin and MDMA. He is currently the

What microdosing did for the perception of psychedelics

Over the past decade, the phenomenon of ‘microdosing’ has had outsized implications for the perception of psychedelics. Before this phenomenon,

Matthew Jonhson: psychedelics are brain plasticity-inducing

By Olivier Taymans Matthew Johnson is associate director of the Center for Psychedelic and Consciousness Research at Johns Hopkins University

« Previous 1 2 3 4 Next »

TICKETS AVAILABLE

The leading academic conference

on psychedelic science.

Academic

Regular

Students

€249

€149

€99